APA

Ross C. J. D., Twisk J., Meulenberg J. M., Liu G., van den Oever K., Moraal E., Hermens W. T., Rip J., Kastelein J. J. P., Kuivenhoven J. A. & Hayden M. R. (20041126). Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation. : Human gene therapy.

Chicago

Ross Colin J D, Twisk Jaap, Meulenberg Janneke M, Liu Guoqing, van den Oever Karin, Moraal Ewoud, Hermens Wim T, Rip Jaap, Kastelein John J P, Kuivenhoven Jan Albert and Hayden Michael R. 20041126. Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation. : Human gene therapy.

Harvard

Ross C. J. D., Twisk J., Meulenberg J. M., Liu G., van den Oever K., Moraal E., Hermens W. T., Rip J., Kastelein J. J. P., Kuivenhoven J. A. and Hayden M. R. (20041126). Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation. : Human gene therapy.

MLA

Ross Colin J D, Twisk Jaap, Meulenberg Janneke M, Liu Guoqing, van den Oever Karin, Moraal Ewoud, Hermens Wim T, Rip Jaap, Kastelein John J P, Kuivenhoven Jan Albert and Hayden Michael R. Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation. : Human gene therapy. 20041126.